Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
4
×
life sciences
national blog main
san francisco blog main
4
×
boston
crispr
editas medicine
gene editing
national top stories
san francisco top stories
biotech
crispr therapeutics
crispr-cas9
deals
feng zhang
intellia therapeutics
abbvie
agios therapeutics
allergan
alzheimer's disease
base editing
branden moriarty
broad institute
cancer
cas13
clinical trials
cynthia collins
david liu
david walt
diagnostics
dna
editas
editor
editr
enzyme
harvard university
illumina
jennifer doudna
jim collins
What
editing
4
×
gene
4
×
crispr
cas
editas
genetic
human
medicine
medicines
abbvie
alliance
beam
bio
biotech
cancer
cells
create
defect
diagnostic
diseases
drive
edited
editor
exits
experimental
fears
fix
flag
founders
gotten
guardian
harvard
heats
high
jump
known
lab
launches
malfunction
mass
Language
unset
Current search:
editing
×
gene
×
" boston top stories "
×
" san francisco blog main "
×
@xconomy.com
3 years ago
AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact
@xconomy.com
5 years ago
CRISPR Diagnostic Race Heats Up as Sherlock Bio Launches With $35M
@xconomy.com
5 years ago
CRISPR Risks? Researchers Stoke Fears of Cancer in Gene-Edited Cells
@xconomy.com
5 years ago
Beam Therapeutics Spotlights CRISPR 2.0 with Precise Gene Editor, $87M